Ati cautat: siguranta medicamente
FDA ar putea autoriza un viitor vaccin impotriva Covid-19 inainte de finalizarea testelor clinice
Protocol terapeutic: N03AX23 – DCI BRIVARACETAMUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AA10 – DCI SIROLIMUS (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XE42 – DCI RIBOCICLIBUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L01XC32 – DCI ATEZOLIZUMAB (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: J05AP56 – DCI SOFOSBUVIRUM+VELPATASVIRUM+VOXILAPREVIRUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: A16AB17 – DCI CERLIPONASUM ALFA (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)
Protocol terapeutic: L04AC11 – DCI SILTUXIMABUM (actualizat FEBRUARIE 2022 conform ordin MS/CNAS NR 564/499/2021)